Mirae Asset Global Investments Co., Ltd. Ironwood Pharmaceuticals Inc Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 5,777 shares of IRWD stock, worth $27,614. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,777
Previous 4,746
21.72%
Holding current value
$27,614
Previous $30,000
23.33%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding IRWD
# of Institutions
244Shares Held
168MCall Options Held
11.2MPut Options Held
28.5K-
Black Rock Inc. New York, NY22.9MShares$109 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA21.6MShares$103 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$78.3 Million18.04% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.3MShares$53.9 Million0.11% of portfolio
-
State Street Corp Boston, MA9.24MShares$44.2 Million0.0% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $732M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...